Learn
The prediabetes A1c range
By ADA criteria, an A1c from 5.7% to 6.4% is in the prediabetes range.
| Category | A1c | Estimated average glucose |
|---|---|---|
| Normal | Below 5.7% | Below 117 mg/dL (6.5 mmol/L) |
| Prediabetes | 5.7% to 6.4% | 117 to 137 mg/dL (6.5 to 7.6 mmol/L) |
| Diabetes | 6.5% or higher | 140 mg/dL or higher (7.8 mmol/L) |
What the range means
- The ADA defines prediabetes as an A1c of 5.7% to 6.4%; it can also be defined by fasting glucose or the OGTT (ADA Standards 2026, sec. 2).
- Prediabetes is a risk factor for type 2 diabetes. Within the range, the higher the A1c, the higher the risk (NIDDK).
- The ADA calls prediabetes an intermediate state between normal and diabetes, with a higher risk of diabetes and of cardiovascular disease (ADA Standards 2026, sec. 2).
- The range is the same at every adult age, although A1c tends to drift up a little with age. See A1c by age.
ADA prediabetes criteria
| Test | Prediabetes range |
|---|---|
| A1c | 5.7% to 6.4% (39 to 47 mmol/mol) |
| Fasting plasma glucose | 100 to 125 mg/dL (5.6 to 6.9 mmol/L) |
| 2-hour glucose during a 75 g oral glucose tolerance test | 140 to 199 mg/dL (7.8 to 11.0 mmol/L) |
ADA Standards 2026, Table 2.2, outside pregnancy; any one of the three tests is enough (ADA Standards 2026, sec. 2).
Why 5.7% and 6.4% are not the same
Within the 5.7% to 6.4% range, the higher the A1c, the greater the risk of diabetes (NIDDK). The ADA adds that for all three tests, risk is continuous: it starts below the lower limit of the range and becomes disproportionately greater at the higher end (ADA Standards 2026, sec. 2). So a 5.7% and a 6.4% carry different risk, even though both count as prediabetes.
How it is confirmed
If you have no symptoms but an A1c shows prediabetes or diabetes, NIDDK says the test should be repeated on a different day, with the A1c or another diabetes test, to confirm the diagnosis (NIDDK). Different tests do not always agree; if your A1c came back high with normal glucose, see high A1c with normal glucose. Conditions that change the life span of red blood cells, such as recent blood loss or a transfusion, can change A1c levels (NIDDK); see when A1c can mislead.
What the DPP trial found
The Diabetes Prevention Program randomly assigned adults with raised glucose to an intensive lifestyle program, metformin, or placebo. The lifestyle program aimed for 7% weight loss and at least 150 minutes of physical activity a week. Over an average of 2.8 years, type 2 diabetes developed 58% less often with the lifestyle program and 31% less often with metformin than with placebo (DPP 2002).
NIDDK says type 2 diabetes may be prevented or delayed with changes such as weight loss and being active most days of the week (NIDDK). Ask your doctor whether a program like this is right for you.
Not tested yet? Our sister site Uncover My Risk has a 7-question type 2 diabetes risk test.
Key values in this range
A1c 5.7% · A1c 6.0% · A1c 6.4% · A1c 6.5% (diabetes threshold)
Frequently asked questions
What is the A1c range for prediabetes?
5.7% to 6.4%, by ADA criteria. Below 5.7% is normal and 6.5% or higher is in the diabetes range.
Is an A1c of 5.7% the same as 6.4%?
No. Both are in the prediabetes range, but within it, the higher the A1c, the greater the risk of diabetes. The ADA notes that risk is continuous and rises disproportionately at the higher end of the range.
Does one A1c result in this range mean I have prediabetes?
If you have no symptoms, NIDDK says a result in the prediabetes or diabetes range should be repeated on a different day, with the A1c test or another diabetes test, to confirm the diagnosis.
Can prediabetes go back to normal?
In the Diabetes Prevention Program, a lifestyle program with weight loss and physical activity cut new cases of type 2 diabetes by 58% compared with placebo. NIDDK says lifestyle changes may prevent or delay type 2 diabetes. What fits your situation is a decision to make with your health care professional.
Sources
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(Suppl 1). doi.org/10.2337/dc26-S002
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH). The A1C Test & Diabetes. www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test
- Diabetes Prevention Program Research Group (Knowler WC, et al.). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. doi.org/10.1056/NEJMoa012512
Written and maintained by the controla1clevels.com editorial team. We do not have a medical reviewer; every claim links to its primary source above. Last reviewed: 2026-10-28. Spotted an error? See About.